WisGen Biosciences CO. Ltd., Ltd. was established in 2020. It is a biotechnology company with independent intellectual property rights and an innovative molecular diagnosis customized platform. Based on CapSeq® probe capture technology,XMPseq® multiplex PCR technology ,MP-Lamp ® multiplex fluorescent PCRtechnology and EnzySyn® 2.0 system, we will improve the production and sales platform of life science such as probes, reagents, enzymes and magnetic beads, and provide new impetus for independent domestic manufacturing of life science in China.

      WisGen Biosciences has established an independent molecular testing laboratory and GMP workshop. With excellent technology and product performance, it has formed a stable and mature technical service and product system in the fields of molecular biology such as tumor diagnosis, genetic disease detection and methylation screening. At present, it has reached close cooperation with many scientific research institutions, IVD enterprises, medical testing laboratories and gene testing companies.